EastPharma Ltd. reported revenue results for the nine months of 2012. For the period, the company reported revenue of USD 170.8 million, down 14.1% from the same period in 2011 of USD 198.8 million. EastPharma's sales decrease was driven by decreased volumes in DEVA's Human Pharma Products businesses.
1st Jan change | Capi. | |
---|---|---|
+25.40% | 4.55TCr | |
+34.52% | 2.45TCr | |
+27.12% | 1.65TCr | |
+21.19% | 1.47TCr | |
+71.91% | 1.43TCr | |
-0.05% | 678.76Cr | |
-11.84% | 673.29Cr | |
+18.15% | 586.92Cr | |
-8.87% | 572.55Cr |